Data from two of the four studies of Ki-67/MiB1 supported a predictive role in the prognosis of anal cancer patients treated with chemoradiotherapy (Grabenbauer et al, 1998; Ajani et al, 2009). Here, MKI67 is linked to anal carcinoma.